Share class: Shenyang Xingqi Pharmaceutical Co.,Ltd.

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 175,249,247 119,234,614 ( 68.04 %) 0 68.04 %

Major shareholders: Shenyang Xingqi Pharmaceutical Co.,Ltd.

NameEquities%Valuation
China Southern Asset Management Co., Ltd.
1.486 %
2,800,771 1.486 % 28 M ¥
Franklin Templeton Sealand Fund Management Co., Ltd.
0.687 %
1,294,617 0.687 % 13 M ¥
0.4077 %
768,320 0.4077 % 8 M ¥
China Merchants Fund Management Co., Ltd.
0.3906 %
736,012 0.3906 % 7 M ¥
Golden Trust Sinopac Fund Management Co., Ltd.
0.3673 %
692,140 0.3673 % 7 M ¥
China Asset Management Co., Ltd.
0.3542 %
667,552 0.3542 % 7 M ¥
Fullgoal Fund Management Co., Ltd.
0.335 %
631,382 0.335 % 6 M ¥
Zhong Ou Asset Management Co., Ltd
0.3275 %
617,157 0.3275 % 6 M ¥
Chang Xin Asset Management Co., Ltd.
0.2915 %
549,340 0.2915 % 6 M ¥
Huatai-PineBridge Fund Management Co., Ltd.
0.2551 %
480,664 0.2551 % 5 M ¥
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
NameEquities%Valuation
3.8 %
1,536,640 3.8 % 16 M ¥

Breakdown by shareholder type

Institutional7.07%
Individuals1.22%
Unknown91.71%

Based on 1000 largest holdings

Geographical origin of shareholders

China
6.94%
Individuals
1.22%
United Kingdom
0.13%
Hong Kong
0.01%

Based on 1000 largest holdings

Logo Shenyang Xingqi Pharmaceutical Co.,Ltd.
SHENYANG XINGQI PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of ophthalmic drugs. The Company’s main products are ophthalmic prescription drugs, including corneal repairing drugs, anti-bacteria drugs, artificial tears, anti-inflammation drugs, anti-allergic drugs, as well as anti-hyperemia & fatigue relief drugs and others. The Company mainly distributes its products within domestic market.
Employees
2,426
More about the company